3 research outputs found
The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific
We discuss the experience of some Pacific island countries in introducing the new WHO-recommended treatment protocol for lymphatic filariasis—a triple-drug therapy composed of ivermectin, diethylcarbamazine, and albendazole. The successful rollout of the new treatment protocol was dependent on strong partnerships among these countries’ ministries of health, WHO, and other stakeholders. Effective communication among these partners allowed for lessons learned to cross borders and have a positive impact on the experiences of other countries. We also describe various challenges confronted during this process and the ways these countries overcame them
Low Level of Hepatitis B Virus Infection in Children 20 Years after Initiation of Infant Vaccination Program in Wallis and Futuna
Dementia prevalence and incidence among the Indigenous and non-Indigenous populations of the Northern Territory
Objective: To estimate the prevalence and incidence of dementia in Northern Territory Indigenous and non-Indigenous populations